Home LiteratureArticle Details
PMID: 9211946 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Involvement of stress-activated protein kinase and p38/RK mitogen-activated protein kinase signaling pathways in the enhanced phosphorylation of initiation factor 4E in NIH 3T3 cells.

The Journal of biological chemistry ·Vol. 272 ·No. 28 ·1997-07-11 ·Pages 17887-93

Morley SJ, McKendrick L

Abstract

The initiation factor (eIF) 4E is regulated by modulating both the phosphorylation and the availability of the protein to participate in the initiation process. Here we show that either serum treatment or activation of the stress-activated protein kinase (JNK/SAPK) led to enhanced phosphorylation of eIF4E in quiescent NIH 3T3 cells. Although the immunosuppressant, rapamycin, was found to stabilize the association of eIF4E with its negative regulator, 4E-BP1, this drug did not prevent the early effects of serum stimulation on the overall rate of translation, polysome formation, the phosphorylation status of eIF4E, or the recruitment of eIF4E into the eIF4F complex. However, the rapid enhancement of eIF4E phosphorylation in response to serum was largely prevented by the inhibitor of mitogen-activated protein (MAP) kinase activation, PD98059. Activation of the JNK/SAPK signaling pathway with anisomycin resulted in enhanced phosphorylation of eIF4E, which was prevented by either rapamycin or the highly specific p38 MAP kinase inhibitor, SB203580. These data illustrate that multiple signaling pathways, including those of distinct members of the MAP kinase family, mediate the phosphorylation of eIF4E and that the association of eIF4E with 4E-BP1 does not necessarily prevent phosphorylation of eIF4E in vivo.

MeSH Terms
3T3 Cells Adaptor Proteins, Signal Transducing Animals Anisomycin/pharmacology Blood Calcium-Calmodulin-Dependent Protein Kinases/metabolism Carrier Proteins Cell Cycle Proteins Enzyme Activation Enzyme Inhibitors/pharmacology Eukaryotic Initiation Factor-4E Eukaryotic Initiation Factors Flavonoids/pharmacology JNK Mitogen-Activated Protein Kinases Mice Mitogen-Activated Protein Kinases Peptide Initiation Factors/metabolism Phosphoproteins/metabolism Phosphorylation Polyenes/pharmacology Protein Serine-Threonine Kinases/metabolism Protein Synthesis Inhibitors/pharmacology Ribosomal Protein S6 Kinases Ribosomes/metabolism Signal Transduction Sirolimus p38 Mitogen-Activated Protein Kinases
Chemicals
Adaptor Proteins, Signal Transducing Carrier Proteins Cell Cycle Proteins Eif4ebp1 protein, mouse Enzyme Inhibitors Eukaryotic Initiation Factor-4E Eukaryotic Initiation Factors Flavonoids Peptide Initiation Factors Phosphoproteins Polyenes Protein Synthesis Inhibitors Anisomycin Protein Serine-Threonine Kinases Ribosomal Protein S6 Kinases Calcium-Calmodulin-Dependent Protein Kinases JNK Mitogen-Activated Protein Kinases Mitogen-Activated Protein Kinases p38 Mitogen-Activated Protein Kinases 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one Sirolimus
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Morley S J
Biochemistry Laboratory, School of Biological Sciences, University of Sussex, Falmer, Brighton BN1 9QG, United Kingdom. s.j.morley@sussex.ac.uk
McKendrick L
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
1997-07-11
Pages
17887-93
Language
English
Region
United States
NLM ID
2985121R
Subset
IM
Grants
Wellcome Trust · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com